Supernus Pharmaceuticals Inc (SUPN)
28.88
-0.12
(-0.41%)
USD |
NASDAQ |
Apr 18, 16:00
28.88
0.00 (0.00%)
Pre-Market: 20:00
Supernus Pharmaceuticals Cash from Operations (TTM): 111.08M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 111.08M |
| September 30, 2023 | 93.69M |
| June 30, 2023 | 71.66M |
| March 31, 2023 | 161.65M |
| December 31, 2022 | 116.83M |
| September 30, 2022 | 138.02M |
| June 30, 2022 | 120.07M |
| March 31, 2022 | 95.23M |
| December 31, 2021 | 127.13M |
| September 30, 2021 | 110.30M |
| June 30, 2021 | 120.01M |
| March 31, 2021 | 165.68M |
| December 31, 2020 | 138.40M |
| September 30, 2020 | 150.26M |
| June 30, 2020 | 182.32M |
| March 31, 2020 | 119.05M |
| December 31, 2019 | 143.13M |
| September 30, 2019 | 132.19M |
| June 30, 2019 | 156.98M |
| March 31, 2019 | 134.85M |
| December 31, 2018 | 128.99M |
| September 30, 2018 | 132.47M |
| June 30, 2018 | 109.03M |
| March 31, 2018 | 128.42M |
| December 31, 2017 | 114.64M |
| Date | Value |
|---|---|
| September 30, 2017 | 103.24M |
| June 30, 2017 | 92.48M |
| March 31, 2017 | 83.31M |
| December 31, 2016 | 66.81M |
| September 30, 2016 | 61.80M |
| June 30, 2016 | 35.45M |
| March 31, 2016 | 31.65M |
| December 31, 2015 | 34.52M |
| September 30, 2015 | 20.86M |
| June 30, 2015 | 14.26M |
| March 31, 2015 | -5.656M |
| December 31, 2014 | -24.50M |
| September 30, 2014 | -40.18M |
| June 30, 2014 | -51.02M |
| March 31, 2014 | -59.83M |
| December 31, 2013 | -57.95M |
| September 30, 2013 | -64.67M |
| June 30, 2013 | -60.42M |
| March 31, 2013 | -54.35M |
| December 31, 2012 | -47.20M |
| September 30, 2012 | -39.32M |
| June 30, 2012 | -37.12M |
| March 31, 2012 | -36.45M |
| December 31, 2011 | -36.18M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
71.66M
Minimum
Jun 2023
182.32M
Maximum
Jun 2020
129.14M
Average
127.13M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Dynavax Technologies Corp | 100.56M |
| Ligand Pharmaceuticals Inc | 49.58M |
| Pacira BioSciences Inc | 154.65M |
| Esperion Therapeutics Inc | -135.49M |
| Collegium Pharmaceutical Inc | 274.75M |